Re: Riv data delayed to Q2 '19
I see twtr spec that data delay could be related to a 'manuf issue'. Not sure if this is baseless or if anyone here has heard same?
fyi,for newbies, there had been a manufacturing issue which delayed P3 launch years ago. Seem to recall it was PFE-related ,but as noted it did delay initial enrollment of the dispositive trial and GLYC's milestone tied to same.
Others speculating that a Raise c/b coming.
my hope is that there's a purely technical move down to oversold levels in $12s(or ?)to re-add markedly.
Still think 1271s a gem that will likely result in GLYC's acquisition & also that RIV data will eventually support a PFE NDA